61
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion

, , &
Pages 403-408 | Published online: 22 Feb 2017

Figures & data

Table 1 Demographic and clinical characteristics of the patients

Figure 1 Intravitreal injection intervals before and after the switch from ranibizumab to aflibercept.

Notes: Boxes show the median and the 1st and 3rd quartiles. Whiskers extend to the most extreme data point, which is no more than 1.5 times the interquartile range from the box. P-value, Mann–Whitney U-test. n=15.
Figure 1 Intravitreal injection intervals before and after the switch from ranibizumab to aflibercept.

Figure 2 Intravitreal injection intervals just before and after the switch from ranibizumab to aflibercept.

Notes: The “interval just before the switch” refers to the interval from the last injection of ranibizumab to the first injection of aflibercept. “Just after the switch” is the interval between the first and the second injections of aflibercept. Boxes show the median and the 1st and 3rd quartiles. Whiskers extend to the most extreme data point, which is no more than 1.5 times the interquartile range from the box. P-value, Wilcoxon signed-rank test. n=15.
Figure 2 Intravitreal injection intervals just before and after the switch from ranibizumab to aflibercept.

Figure 3 CRT during the study period.

Notes: Boxes show the median and the 1st and 3rd quartiles. Whiskers extend to the most extreme data point, which is no more than 1.5 times the interquartile range from the box. P-value, Mann–Whitney U-test. n=15.
Abbreviation: CRT, central retinal thickness.
Figure 3 CRT during the study period.

Figure 4 BCVA after the switch to aflibercept.

Notes: The plots show the mean values ± standard deviation. The numbers shown in parentheses are decimal visual acuity (converted from mean logMAR). n=15 (0, 3, and 6 months), n=7 (12 months).
Abbreviations: BCVA, best-corrected visual acuity; logMAR, logarithm of minimal angle of resolution.
Figure 4 BCVA after the switch to aflibercept.